Dawn Health Secures €11.5 Million to Scale Platform & Product Suite for Next-Gen Pharma Digital Health Solutions May 5, 2025
RAKEZ Receives Silver Award at MECHF 2025 for Excellence In Facility Management and Sustainability May 5, 2025
VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program May 5, 2025
Nanobiotix Announces Full Results From Completed Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Pancreatic Cancer May 5, 2025
Unlocking Drug Delivery to the Brain: Phase 3 Pivotal Trial Uses Ultrasound to Break Through the Blood-Brain Barrier | By: Michael Canney, Ph.D., is Chief Scientific Officer at Carthera May 1, 2025
